Hepatocellular Cancer

Researchers from Yang Ming National University Detail New Studies and Findings in the Area of Hepatocellular Cancer

Published in Blood Weekly, February 2nd, 2012

2012 FEB 2 -- In this recently published study, investigators in Taipei, Taiwan conducted a study "To evaluate the impact of age on the prognosis of patients with hepatocellular carcinoma (HCC) undergoing percutaneous radiofrequency ablation (RFA). Whether age plays an important role in the outcomes of HCC after RFA remains controversial."

"Two hundred fifty-eight consecutive treatment naive HCC patients who underwent RFA were enrolled. Patients aged <65 years (n=100) were defined as the younger group and those aged >65 years (n = 158) were the elderly group. Their clinicopathologic features and prognosis were compared. Younger patients had a higher...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2012-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry